DISPOSITION OF HYPOGLYCEMIC SULFONYLUREA CS476

被引：0

作者：

TAYLOR, T

GOTFREDSEN, C

CHASSEAUD, LF

ELSOM, LF

FRANKLIN, ER

机构：

[1] HUNTINGDON RES CTR,DEPT METAB & PHARMACOKINET,HUNTINGDON PE18 6ES,ENGLAND

[2] NOVO IND AS,DEPT PHARMACOL,DK-2880 BAGSVAERD,DENMARK

来源：

ACTA PHARMACOLOGICA ET TOXICOLOGICA | 1977年 / 41卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：25 / 32

页数：8

共 16 条

[1]

AUMULLER W, 1966, ARZNEI-FORSCHUNG, V16, P1640

[2]

BRODIE RR, 1976, ARZNEIMITTEL-FORSCH, V26, P896

[3] PHARMACOLOGY AND MODE OF ACTION OF HYPOGLYCAEMIC SULPHONYLUREAS AND DIGUANIDES [J].

DUNCAN, LJP ;

CLARKE, BF .

ANNUAL REVIEW OF PHARMACOLOGY, 1965, 5 :151-&

[4] A NEW ANTI-DIABETIC PRINCIPLE [J].

FRANKE, H ;

FUCHS, J .

DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1955, 80 (40) :1449-1452

[5] METABOLISM AND KINETICS OF HYPOGLYCEMIC AGENT GLIPIZIDE IN MAN - COMPARISON WITH GLIBENCLAMIDE [J].

FUCCELLA, LM ;

TAMASSIA, V ;

VALZELLI, G .

JOURNAL OF CLINICAL PHARMACOLOGY, 1973, 13 (2-3) :68-75

[6]

GOLDANIG.GC, 1973, ARZNEIMITTEL-FORSCH, V23, P242

[7] DYNAMICS OF SULFONYLUREA-INDUCED INSULIN RELEASE FROM ISOLATED PERFUSED RAT PANCREAS [J].

GOTFREDSEN, CF .

DIABETOLOGIA, 1976, 12 (04) :339-342

[8]

HAWKINS DR, 1976, J LABEL CPDS, V13, P75

[9]

JORGENSEN KD, 1977, ACTA PHARMACOL TOX, V40, P216

[10]

KELLNER HM, 1969, ARZNEI-FORSCHUNG, V19, P1388

← 1 2 →